C Ropartz

1.7k total citations
157 papers, 1.4k citations indexed

About

C Ropartz is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, C Ropartz has authored 157 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 40 papers in Immunology and 31 papers in Molecular Biology. Recurrent topics in C Ropartz's work include Blood groups and transfusion (37 papers), Monoclonal and Polyclonal Antibodies Research (25 papers) and Immunodeficiency and Autoimmune Disorders (25 papers). C Ropartz is often cited by papers focused on Blood groups and transfusion (37 papers), Monoclonal and Polyclonal Antibodies Research (25 papers) and Immunodeficiency and Autoimmune Disorders (25 papers). C Ropartz collaborates with scholars based in France, Switzerland and Germany. C Ropartz's co-authors include L Rivat, C. Rivat, J. Lenoir, Maryvonne Daveau, Jacques Loiselet, Marie‐Paule Lefranc, Danièle Gilbert, J.P. Martin, Josiane Martin and Richard Sesboüé and has published in prestigious journals such as Nature, The Lancet and JNCI Journal of the National Cancer Institute.

In The Last Decade

C Ropartz

137 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Ropartz France 22 455 436 403 367 251 157 1.4k
Ronald Billing United States 21 505 1.1× 542 1.2× 770 1.9× 360 1.0× 206 0.8× 74 1.6k
A. M. Wu United States 16 319 0.7× 431 1.0× 293 0.7× 127 0.3× 204 0.8× 27 1.1k
Y Mory Israel 17 270 0.6× 731 1.7× 309 0.8× 174 0.5× 209 0.8× 26 1.5k
Gabriel Goldberger United States 22 312 0.7× 774 1.8× 737 1.8× 166 0.5× 113 0.5× 33 1.7k
Amiel G. Cooper United States 22 224 0.5× 493 1.1× 269 0.7× 176 0.5× 77 0.3× 49 1.3k
Cécile Tonnelle France 23 523 1.1× 559 1.3× 1.0k 2.5× 459 1.3× 181 0.7× 55 1.9k
Richard A. Patrick United States 8 206 0.5× 298 0.7× 877 2.2× 214 0.6× 108 0.4× 16 1.5k
A. Bargellesi Italy 24 252 0.6× 505 1.2× 890 2.2× 534 1.5× 74 0.3× 57 1.8k
R Ceppellini Italy 26 429 0.9× 360 0.8× 916 2.3× 489 1.3× 238 0.9× 75 1.9k
ED Ball United States 22 911 2.0× 548 1.3× 387 1.0× 147 0.4× 143 0.6× 47 1.5k

Countries citing papers authored by C Ropartz

Since Specialization
Citations

This map shows the geographic impact of C Ropartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Ropartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Ropartz more than expected).

Fields of papers citing papers by C Ropartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Ropartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Ropartz. The network helps show where C Ropartz may publish in the future.

Co-authorship network of co-authors of C Ropartz

This figure shows the co-authorship network connecting the top 25 collaborators of C Ropartz. A scholar is included among the top collaborators of C Ropartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Ropartz. C Ropartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ropartz, C, et al.. (1998). [Frequency of the Inv (a) factor in the aborigines of Western Australia].. PubMed. 2. 86–90.
2.
Cavelier, B, et al.. (1978). [Study of a population carrying HLA B27 antigen compared with a population without B27, in the detection of ankylosing spondylitis].. PubMed. 45(4). 275–82. 5 indexed citations
3.
Martin, Josiane, et al.. (1976). Genetic Variants of Serum &alpha;<sub>1</sub>-Antitrypsin (Pi Types) in Portuguese. Human Heredity. 26(4). 310–314. 21 indexed citations
4.
Charlionet, Roland, et al.. (1976). Is there a relationship between alpha-1-antitrypsin Pi MZ phenotype and hepatoma?. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 25(4). 125–6. 12 indexed citations
5.
Rivat, C., et al.. (1976). Heavy and light chain variable region subgroups: antigenic analysis among human monoclonal immunoglobulins.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 127(3-4). 303–15. 1 indexed citations
6.
Daveau, Maryvonne, et al.. (1975). Gm and Inv Allotypes in a Gypsy Sample. Human Heredity. 25(2). 135–143. 15 indexed citations
7.
Daveau, Maryvonne, et al.. (1975). Gm and Inv Allotypes in French Guiana Indians. Human Heredity. 25(2). 88–92. 15 indexed citations
8.
Rivat, L, et al.. (1972). Ten Gm Factors and the Inv System in Eskimos in Greenland. Human Heredity. 22(5-6). 519–528. 2 indexed citations
9.
Ropartz, C, et al.. (1972). Frequency of Gm, Inv and ISf Phenotypes in the Population of 4 Yugoslavian Villages. Human Heredity. 22(5-6). 508–518. 10 indexed citations
10.
Rivat, C., et al.. (1970). Accident survenu après injection de gamma-globulines anti-Rh dû à la présence d'anticorps anti-gammaA.. La Presse Médicale. 78(47). 2072–2072. 5 indexed citations
11.
Ropartz, C, et al.. (1970). Maladie de Kahler familiale. Etude immunologique et caryotypique d'une observation.. La Presse Médicale. 78(40). 5 indexed citations
12.
Rivat, C., et al.. (1967). Une immunoglobulinopathie méconnue: la maladie des chaines lourdes.. La Presse Médicale. 75(45). 13 indexed citations
13.
Ropartz, C, et al.. (1966). Seven new Human Serum Factors Presumably Supported by the Gamma‐Globulins*. Vox Sanguinis. 11(1). 99–102. 8 indexed citations
14.
Ritter, H., et al.. (1966). Formale Genetik und Populationsgenetik des Inv-Polymorphismus. Annals of Hematology. 13(6). 373–377. 14 indexed citations
15.
Ropartz, C, et al.. (1964). On the Frequency of the Gm- and Inv-Serum Groups in South-Western Germany. Human Heredity. 14(3-4). 298–308. 8 indexed citations
16.
Ropartz, C, et al.. (1964). Les groupes de gamma-globulines Gm et Inv parmi la population d’Honolulu (Hawaï). Human Heredity. 14(1). 25–35. 3 indexed citations
17.
Ropartz, C, et al.. (1964). [GAMMA GLOBULIN GROUPS GM AND INV AMONG THE POPULATION OF HONOLULU (HAWAII)].. PubMed. 14. 25–35. 1 indexed citations
18.
Ropartz, C, et al.. (1963). Les Systèmes Gm et Inv en Europe. Human Heredity. 13(2). 109–123. 23 indexed citations
19.
Pelt, Jos van, et al.. (1962). Varia. Human Heredity. 12(1). 96–96.
20.
Ropartz, C, et al.. (1962). Répartition des groupes de gammaglobulines: Gm et InV chez les Iraniens. Human Heredity. 12(1). 45–50. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald Billing Breakdown of academic impact, for papers by A. M. Wu Breakdown of academic impact, for papers by Y Mory Breakdown of academic impact, for papers by Gabriel Goldberger Breakdown of academic impact, for papers by Amiel G. Cooper Breakdown of academic impact, for papers by Cécile Tonnelle Breakdown of academic impact, for papers by Richard A. Patrick Breakdown of academic impact, for papers by A. Bargellesi Breakdown of academic impact, for papers by R Ceppellini Breakdown of academic impact, for papers by ED Ball
Rankless by CCL
2026